Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kameran Daham"'
Autor:
Jeanette Grundström, Barbro Dahlén, Guro Gafvelin, Sven-Erik Dahlén, Kameran Daham, Maria Edin Grimheden, Marianne van Hage, Sara Sánchez Vidaurre
Publikováno v:
International Archives of Allergy and Immunology. 170:57-61
Background: Selective inhibition of cyclooxygenase-2 (COX-2) reduces the production of prostaglandin E2 (PGE2), which can have both pro- and anti-inflammatory effects on allergic inflammation. Moreover, in vitro PGE2 has been shown to affect inflamma
Publikováno v:
Journal of Global Oncology. 5:99-99
99 Background: For patients with NSCLC clinical stages I and II disease with no medical contraindications, surgery is treatment of choice showing 5-year survival rates of about 60–80% for stage I and 40–50% for stage II, respectively. However, fo
Autor:
Johan Larsson, David Balgoma, Joshua Rokach, Sven-Erik Dahlén, Craig E. Wheelock, John A. Lawson, Kameran Daham, Barbro Dahlén
Publikováno v:
Analytical Chemistry. 85:7866-7874
Eicosanoids (e.g., prostaglandins and leukotrienes) are inflammatory signaling molecules that are metabolized and excreted in urine. The quantification of eicosanoid metabolites in human urine has been demonstrated to provide insight into the inflamm
Autor:
Noritaka Higashi, Barbro Dahlén, Pär Gyllfors, Anna James, Maria Skedinger, Ai Higashi, Flora Gaber, Agneta Lindeberg, Sven-Erik Dahlén, Kameran Daham, Ingrid Delin, Maria Kumlin
Publikováno v:
International Archives of Allergy and Immunology. 158:299-306
Background: There is no in vitro test to diagnose aspirin-intolerant asthma (AIA). The aim of this study was to test if challenge with aspirin of sputum cells from subjects with AIA triggers the release of cysteinyl leukotrienes (CysLTs), known to be
Autor:
Wen-Liang Song, John A. Lawson, Maciek Kupczyk, Barbro Dahlén, Kameran Daham, Dahlén Se, Garret A. FitzGerald, A. Gülich
Publikováno v:
Clinical & Experimental Allergy. 41:36-45
Summary Background Prostaglandin (PG) D2 is a pro-inflammatory and bronchoconstrictive mediator released from mast cells, and is currently evaluated as a new target for treatment of asthma and rhinitis. It is not known which cyclooxygenase (COX) isoe
Autor:
Sven-Erik Dahlén, Marianne van Hage, María José Martínez-Bravo, Pia Larssen, Kameran Daham, Sara Sánchez-Vidaurre, Barbro Dahlén, Susanne Gabrielsson, Maria Eldh
Publikováno v:
Journal of Allergy and Clinical Immunology. 140:1459-1461.e2
Autor:
Flora Gaber, Anna James, Agneta Gulich, Pär Gyllfors, Kameran Daham, Ingrid Delin, Maria Kumlin, Noritaka Higashi, Barbro Dahlén, Magnus Nord, Maria Skedinger, Sven-Erik Dahlén, Ai Higashi
Publikováno v:
Thorax. 63:1076-1082
A diagnosis of aspirin-intolerant asthma requires aspirin provocation in specialist clinics. Urinary leukotriene E(4) (LTE(4)) is increased in aspirin-intolerant asthma. A study was undertaken to investigate new biomarkers of aspirin intolerance by c
Autor:
Maciej Kupczyk, David Balgoma, Elisabeth Henriksson, Sven-Erik Dahlén, Bo Billing, Craig E. Wheelock, Garret A. FitzGerald, Agneta Lindeberg, Barbro Dahlén, Kameran Daham, Anna James
Publikováno v:
The Journal of allergy and clinical immunology. 134(2)
Background Prostaglandins that constrict and relax airways are synthesized in reactions catalyzed by either COX-1 or COX-2. It is not known whether selective inhibition of COX-2 makes asthmatic responses better or worse. Objective To determine the ef
Autor:
Barbro Dahlén, Ville Pulkkinen, Seppo Saarelainen, Pinja Ilmarinen, Anna James, Eeva Moilanen, Sven-Erik Dahlén, Hannu Kankaanranta, Kameran Daham, Tarja Laitinen, Juha Kere
Publikováno v:
Peptides. 51
Eosinophils are inflammatory cells of particular relevance to asthma exacerbations. Neuropeptide S (NPS) receptor was identified in a search for asthma susceptibility genes, where the risk haplotypes of the NPS receptor gene associated with total ser
Autor:
Tove Tingvall, Sven-Erik Dahlén, Anna James, Kameran Daham, Hans-Erik Claesson, Linda Backman, Barbro Dahlén, Charlotte Edenius, Åsa Brunnström, Maria Kumlin
Publikováno v:
International archives of allergy and immunology. 162(2)
Background: The effect of aspirin on the release of key arachidonic acid metabolites in activated eosinophils from subjects with aspirin-intolerant asthma (AIA) has not been investigated previously, despite the characteristic eosinophilia in AIA. Met